Biopharmaceuticals & Biotechnology

2023 PDA Particle Control in Biopharmaceuticals

Roman Mathaes, Clear Solutions Laboratories

On The Issue: Next Gen ATMP Production

PDA, Inc.

On the Issue: The PDA Virus Conference Chairs

PDA, Inc.

2022 PDA BioManufacturing Conference Lands in Amsterdam

Co-Chairs Cristiana Campa, PhD, GSK and Raf De Dier, PhD, Janssen

A Successful Q-Model for New mRNA Line Commissioning & Qualification: Pt. 2

Ahmed Elsaid, Emergent BioSolutons, and Ajay Pazhayattil, Capcium Inc.

PDA BioManufacturing and Lyophilization Conferences: The Start of a Shared Journey

Cristiana Campa, PhD, GSK; Michael R. DeFelippis, PhD, Eli Lilly; Raf De Dier, PhD, Janssen; and Anthony Cannon, MSD

Accelerated COVAX Approvals Maintained Rigorous Review Process

Adam Caruso, Merck & Co.

New Frontiers in Developing and Manufacturing Vaccines

Marilyn Foster, PDA, Inc.

Accelerating Biopharmaceutical Innovation in Health Emergencies

Michael De Felippis, Eli Lilly and Cristiana Campa, GSK Vaccines

Think Globally, Work Virtually in the Era of COVID-19: The Future of Biotech Success

Ali Ardakani, Novateur Ventures and Fenton Fong, xCellarate Technology

T-Cell Therapy Saves a Life

Marilyn L. Foster, PDA

PDA Survey Results: Current State of Cryopreservation

Brian J. Hawkins, Raluca Marcu, Pluristyx, Inc.

PDA IG Explores Next-Gen Sequencing for Viruses

Rebecca Stauffer, PDA

Cryogenic Storage Challenges for Container-Closure Systems

Pascal Sircoulomb, ARaymondlife, and Luce Sohier, SCHOTT

The Product Quality Leader Team Part II: Getting Ahead

Stephan Krause, PhD; Mariam Khan; Callum Chapman; Rob Gaglione; Andy Spasoff; Anthony Mire-Sluis, AstraZeneca

Inaugural BioManufacturing Conference Tackles Five Key Issues: Part II

Michael De Felippis, PhD, Eli Lilly, and Cristiana Campa, PhD, GSK 

Panel Inspires Next Generation of Female Biotech Leaders

Tony Yang, Communications Board Chair, Pacific Northwest Chapter

Add Sherlock Holmes to Your Investigation Team

Tony Cundell, PhD, Microbiological Consulting, LLC

Can We Reprogram the Human Computer?

Rebecca Stauffer, PDA

Conference Puts Human Face on Cell and Gene Therapies

Rebecca Stauffer, PDA

Avoid Unmixed Process Solutions

Dosung Kim, Jeonghun Kim, Kwangjun Yoon, Denis Rigolet and Anthony R. Newcombe, Polus, Inc.

Viruses on the Surface

Jennifer Loughman and Paul Lopolito, STERIS

Can the Power of Viruses be Harnessed for Good?

Brian Hawkins, PhD, Pluristyx, Inc.

Biopharma Offers New Opportunities

Cristiana Campa, GSK, and Michael De Felippis, Eli Lilly and Company

How to Best Tackle Biosimilar Challenges

Stephan Krause, PhD, AstraZeneca Biologics, and Jens Schletter, PhD, Novartis

Getting Biosimilars Right the First Time

Barbara Rellahan, Amgen